Following a warning from the U.S. Food and Drug Administration (FDA) regarding Tussionex cough syrup on March 11^{th, information regarding the safe administration of the prescription drug has been released.The FDA recommends that no child under the age of 6 should be prescribed Tussionex under any circumstance.}

The cough syrup should only be taken in 12 hour increments. Overdose may result from taking Tussionex in increments more frequent than the recommended doses.

Symptoms of a Tussionex overdose include:

o Trouble breathing, including slow or shallow breathing

o Slow heart rate

o Sleepiness

o Cold, clammy skin

o Trouble walking or talking

o Feeling faint, dizzy or confused

Serious illness and death have been reported in connection with Tussionex. Defective drug attorneys are currently working on cases involving the mislabeling of prescription drug products.

On March 11^{th, 2008, the U.S. Food and Drug Administration (FDA) announced a warning regarding the prescription cough syrup, Tussionex Pennkinetic Extended-Release Suspension.According to the FDA, Tussionex has been linked to death and serious adverse reactions. A report released by the FDA states that Tussionex was improperly prescribed to children under the age of 6 years old and administered more frequently than recommended.}

Tussionex should only be administered in 12 hour increments. Serious side effects have been reported by those who are given the cough syrup at increments of 6 to 8 hours. Frequent administration of Tussionex can result in overdose, leading to death.

Reports of the serious side effects of Tussionex have also been reported in adults and adolescents.

The FDA is recommending the manufacturer provide clear information and labeling of Tussionex.

Defective drug attorneys are currently working on cases involving the mislabeling of prescription drugs.